EN
- ES
- EN
Jump Main Menu. Go directly to the main content
Federico Mayor Zaragoza
José María Medina
Encarna Guillén
Pablo Lapunzina
Events
Start of main content
Genomic Medicine
Life and Matter Sciences International Symposium Tuesday and Wednesday, June 4 and 5, 2019 9:30 hours Madrid
General information:
Venue: Fundación Ramón Areces. Calle Vitruvio, 5. 28006. Madrid.
Free admission. Necessary previous online registration. Limited capacity. Simultaneous interpretation.
Organized by:
Fundación Ramón Areces
Coordinator/s:
Pablo Lapunzina INGEMM, Hospital Universitario La Paz y CIBERER-ISCIII, Madrid.
Encarna Guillén Hospital Clínico Universitario Virgen de la Arrixaca, UMU, IMIB y CIBERER-ISCIII. Murcia
Multimedia
Ángel Carracedo's full lecture
Multimedia
Ángel Carracedo's full lecture
Multimedia
María Martin's full lecture
Multimedia
Yves Levy's full lecture
Multimedia
Domenico Coviello's full lecture
Multimedia
Richard Scott's full lecture
Multimedia
Milton Jijón's full lecture
Multimedia
Raquel Yotti's full lecture
Multimedia
Joaquín Arribas's full lecture
Multimedia
Juan Cruz Cigudosa García's full lecture
Multimedia
Alba Ancoechea's full lecture
Multimedia
Antonio Alarcó and José Martínez Olmos's full lecture
Multimedia
Julián Isla's full lecture
Multimedia
Ángel Carracedo's full lecture
- Description
- Programme
Genomic Medicine is a promising new concept for dealing with challenges of health and health systems. With the launch of the International Consortium for Personalised Medicine, which brings together health research funders and policy‐making organizations, European countries aim to coordinate research and health policy to advance the implementation of personalized medicine
The problems and needs of the diagnosis of rare diseases and genetic and genomic studies in our country are:
1) ) At present, neither the National Health System in its entirety nor the health systems of the CCAA have comprehensive diagnostic centers genetic of high diagnostic capacity that can respond to national needs. This implies that each regional health system has to: a) face the cost of genetic studies deriving them abroad or to private centers; b) not doing so, maintaining waiting lists or replacing them by making studies of lower quality and higher cost, which fail to provide a diagnostic response to patients.
2) There is inequity in access to genetic / genomic diagnoses of patients and citizens depending on the health center, the region / autonomous community to which it belongs and the complexity of the hospitals they consult.
3) Each medium-sized hospital (and sometimes small, regional hospitals) is making unprofitable and expensive investments in the purchase of modern small-sized sequencing technologies, when optimization through the creation of comprehensive genomic diagnostic centers reduces costs and increases the diagnostic power of genetic tests using large, much more cost-effective devices.
4) The objectives of the European Horizon 2020 initiative are to guarantee the diagnosis of all genetic-based diseases and at least 200 treatments by the year 2020.
5) Diagnostic genetic tests are tests already included in the portfolio of services of the Ministry of Health (Order SSI / 2065/2014), but their implementation is slowed down partly due to the problems identified above.
Tuesday, June 4th
9:00 h.
Attendee check-in
9:30 h.
Welcome and presentation
Federico Mayor Zaragoza
Scientific Council Fundación Ramón Areces.
José María Medina
Scientific Council Fundación Ramón Areces.
Encarna Guillén
Hospital Clínico Universitario Virgen de la Arrixaca, UMU, IMIB y CIBERER-ISCIII. Murcia. Coordinator.
Pablo Lapunzina
Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz y CIBERER-ISCIII. Madrid.
Session 1: Genomic Medicine in the World
9:45 h.
Moderator: Julián Nevado
Genomic Medicine: the Global Alliance for Genomics and Health
María Martín
European Molecular Biology Laboratory (EMLB) European Bioinformatics Institute (EBI).
10:25 h.
Genomic Medicine: the French initiative
Yves Levy
Hôpital Henri-Mondor, France.
11:05 h.
Break
11:30 h.
Genomic Medicine in Italy
Domenico Coviello
Ospedale Istituto Giannina Gaslini, Italy.
12:10 h.
Genomic Medicine in the UK. The 100,000 genomes Project
Richard Scott
Genomic England, UK.
12:50 h.
Genome Initiatives in South America. The Equator experience and other experiences in South America
Milton Jijón
Fundación Ecuatoriana de Enfermedades Raras, Ecuador.
13:30 h.
Discussion
13:45 h.
Break
Session 2: Genomic Medicine in Spain
15:15 h.
Moderator: Pablo Lapunzina
Genomic Medicine in Spain. A global view
Raquel Yotti
Instituto de Salud Carlos III (ISCIII). Madrid.
16:15 h.
Genomic Medicine in Spain. The Oncology approach
Joaquín Arribas
Centro de Investigación Biomédica en Red Cáncer, CIBERONC - ISCIII. Madrid.
17:00 h.
The 1M Genome Project
Ángel Carracedo
Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER - ISCIII. Universidade de Santiago de Compostela.
Wednesday, June, 5
Session 3
08:30 h.
Moderator: Encarna Guillén
Attendee check-in
9:00 h.
The AEGH (Spanish Association of Human Genetics) perspective
Juan Cruz Cigudosa García
Asociación Española de Genética Humana (AEGH). Madrid.
9:45 h.
Orphan drugs and new treatments for rare disease. Impact for Genomic Medicine and health
Josep Torrent
Hospital de la Santa Creu i Sant Pau. Barcelona.
10:30 h.
The vision of the patients
Alba Ancoechea
Federación Española de Enfermedades Raras (FEDER). Madrid.
11:15 h.
Break
11:45 h.
The report of the Senators about Genomic Medicine
Antonio Alarcó
Senador. Cámara Alta de la Cortes Generales Españolas. Madrid.
José Martínez Olmos
Senador. Cámara Alta de la Cortes Generales Españolas. Madrid.
12:45 h.
A technological and futuristic view of Genomic Medicine
Julián Isla
Health 29. Microsoft Corporation.
13:30 h.
The CIBERER and the Genomic Medicine in Spain
Pablo Lapunzina
Coordinador del simposio.
14:15 h.
Closing remarks and comments
-
Activities related
-
Projects related
-
News related
-
Publications related
-
8
Apr
2024
Panel Discussion Mundo de las prótesis, los nuevos materiales, sus complicaciones y su futuro Madrid , Lunes, 8 de abril 2024. 17.00 horas
-
23
Apr
2024
Session Situación actual de las Enfermedades Raras en España Madrid, Martes, 23 de abril de 2024, 10:00 horas
-
9
May
2024
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas
- Phenotyping of animal models of rare diseases with visual disability 2020 Senior Researcher : Lluís Montoliu José Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
- The neuronal glycine transporter GlyT2 in herplexia: a glycinergic pathology of development 2020 Senior Researcher : Beatriz López Corcuera Research Centre or Institution : Centro de Biología Molecular Severo Ochoa. CSIC - UAM
- Serum markers in patients with congenital melanocytic nevi: clinicopathological and genetic correlation 2020 Senior Researcher : Pedro Redondo Bellón Research Centre or Institution : Clínica Universidad de Navarra. Pamplona
-
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
End of main content